FDA approves Wegovy pill for weight loss
Digest more
Below is a comparison of today’s most prescribed GLP-1 medications, including Ozempic and Trulicity, both widely used for Type 2 diabetes and increasingly discussed for weight support. Patients choosing between these medications often look at factors such as cost, insurance coverage, dosing preference, and weight loss expectations.
A research team in Sweden has developed a new class of oral medicines aimed at type 2 diabetes and obesity, built around a more selective way of activating the beta 2 adrenergic receptor.
Morning Overview on MSN
Diabetes drugs and cancer: the surprising link scientists are seeing
Medications developed to control blood sugar are now at the center of a very different scientific story: how they might raise or lower the odds of developing cancer. As researchers follow millions of people taking these drugs,
Diabetes drugs may be doing more than managing blood sugar, they could also shape cancer biology in unexpected ways.
New weight loss drugs like Wegovy and Zepbound have been heralded as game-changers in tackling obesity, helping people lose significant amounts of weight and potentially prevent Type 2 diabetes. But many doctors caution that these medications have ...
At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and approximately 700 million live with chronic kidney disease. Collectively, these illnesses are the leading cause of death in dozens of countries; the evidence for CKM indicates that the several epidemics may in fact be one.
Share on Pinterest A new study found that certain diabetes medications could help lower the risk of neurodegenerative diseases. FG Trade/Getty Images A team of scientists in Korea recently investigated a group of diabetes medications called gliflozins, or ...
New evidence shows that remission in type 2 diabetes is attainable through weight loss, surgery, pharmacotherapy, and intensive lifestyle change.
The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take two common anti-diabetes medications had a reduced risk of ...